Is Healthpeak Properties (DOC) overvalued or fairly valued?

MarketChacha shows Healthpeak Properties's valuation in context — a trailing P/E of about 78.2, a forward P/E of about 134.3, a price-to-book of about 1.7 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does Healthpeak Properties's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (5.28×) from reported figures — education, not a rating.

What is Healthpeak Properties's revenue?

Healthpeak Properties reported revenue of $604.0M for FY2025, with net profit of $71.3M, per official filings.

What is the share price of Healthpeak Properties (DOC)?

Healthpeak Properties last traded at $18.76 (-1.2% on the day), as of 10/20/2026 — a delayed quote shown for education, not investment advice.

Healthpeak Properties

DOC · NYSE · Real Estate · United States

Snapshot

TickerDOC

ExchangeNYSE

SectorReal Estate

IndustryREIT - Healthcare Facilities

CountryUnited States

Employees411

HeadquartersDenver, United States

Websitewww.healthpeak.com

Filings tracked15

About Healthpeak Properties

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery. Healthpeak Properties, Inc. is based in Denver, Colorado. Healthpeak Properties, Inc. was incorporated in 1985 in Maryland.

Who owns it

Insiders0.3%
Institutions97.8%
Public & other1.9%

1,059 institutional holders

Ownership breakdown from public market data.

Top holders

Blackrock Inc.10.29%
Vanguard Portfolio Management LLC8.47%
Vanguard Capital Management LLC6.53%
State Street Corporation6.38%
JPMORGAN CHASE & CO4.38%
Fuller & Thaler Asset Management Inc.4.22%
Geode Capital Management, LLC3.58%
Invesco Ltd.2.68%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

Margin has compressed by about 46.2 points over the period — profitability is trending down.

Cash conversion5.28×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend58.0% → 11.8%

Margin has compressed by about 46.2 points over the period — profitability is trending down.

Return on equity1.0%

Latest ROE of 1.0% is on the low side — the business earns a modest return on shareholder capital.

Growth qualityrev 7% · PAT -52%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $759.3M · EPS 0.03

Est. earnings growth -68.6%

Next fiscal year

Rev $3.2B · EPS 0.14

Est. earnings growth +55.6%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$604.0M

Net margin

11.8%

ROE

1.0%

Revenue CAGR (2y)

+7.0%

Profit CAGR (2y)

-51.7%

EPS (FY2025)

0.10

Net profit (FY2025)

$71.3M

Ask MarketChacha about DOC

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$604.0M	$71.3M	0.10	11.8%	1.0%
FY2024	$568.5M	$243.1M	0.36	42.8%	2.9%
FY2023	$527.4M	$306.0M	0.56	58.0%	4.8%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$216.5M	$52.8M	0.08	24.4%
2026Q1	$200.3M	$193.6M*	0.28	—
2025Q3	$150.5M	$-117.1M	-0.17	-77.8%
2025Q2	$148.9M	$31.7M	0.05	21.3%
2025Q1	$148.9M	$42.8M	0.06	28.8%
2024Q3	$142.8M	$85.9M*	0.12	—
2024Q2	$140.9M	$146.0M*	0.21	—
2024Q1	$138.8M	$6.7M	0.01	4.8%
2023Q3	$133.8M	$64.2M	0.12	48.0%
2023Q2	$130.2M	$51.9M	0.09	39.9%
2023Q1	$127.1M	$119.0M*	0.22	—

* Net profit includes one-off / non-operating items (e.g. a settlement or accounting gain), so it doesn’t reflect operating performance — net margin is hidden for that period.

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

10-Q filing
SEC8/5/2026
8-K — Results of operations, Reg FD disclosure, Exhibits
SEC8/4/2026material
10-Q filing
SEC5/6/2026
8-K — Results of operations, Reg FD disclosure, Exhibits
SEC5/5/2026material
8-K — Shareholder vote results
SEC5/4/2026material
8-K — Material agreement, Material financial obligation, Exhibits
SEC3/23/2026material
8-K — Reg FD disclosure
SEC2/27/2026material
10-K filing
SEC2/3/2026
8-K — Results of operations, Reg FD disclosure, Exhibits
SEC2/2/2026material

2025

10-Q filing
SEC10/24/2025
8-K — Results of operations, Reg FD disclosure, Exhibits
SEC10/23/2025material
8-K — Other events, Exhibits
SEC8/14/2025material
8-K — Other events, Exhibits
SEC8/6/2025material
8-K — Other events, Exhibits
SEC8/5/2025material
10-Q filing
SEC7/25/2025

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.